Nephros (NEPH) EBITDA Margin (QoQ) (2010 - 2026)
Nephros (NEPH) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.86 Bn | 129.64 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.52 Bn | 51.66 Bn | 2.32 Bn |
| 3 | Alcon | 35.73 Bn | 34.38 Bn | 1.68 Bn |
| 4 | Resmed | 34.00 Bn | 32.53 Bn | 861.22 Mn |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.80 Bn | 24.37 Bn | 329.20 Mn |
| 7 | Solventum | 15.29 Bn | 14.89 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn |
| 9 | Baxter International | 13.64 Bn | 11.49 Bn | 1.03 Bn |
| 10 | Nephros | 47.98 Mn | 43.29 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,830.00 |
| Mar 31, 2026 | 148.00 |
| Dec 31, 2025 | -621.00 |
| Sep 30, 2025 | 98.00 |
| Jun 30, 2025 | -599.00 |
| Mar 31, 2025 | 341.00 |
| Dec 31, 2024 | 234.00 |
| Sep 30, 2024 | 1,560.00 |
| Jun 30, 2024 | -407.00 |
| Mar 31, 2024 | 1,427.00 |
| Dec 31, 2023 | -1,452.00 |
| Sep 30, 2023 | 685.00 |
| Jun 30, 2023 | -399.00 |
| Mar 31, 2023 | 1,881.00 |
| Dec 31, 2022 | 2,608.00 |
| Sep 30, 2022 | -2,461.00 |
| Jun 30, 2022 | 4,309.00 |
| Mar 31, 2022 | -4,508.00 |
| Dec 31, 2021 | 453.00 |
| Sep 30, 2021 | 1,818.00 |